SER

Serina Therapeutics, Inc.

2.50

USD

SER Earnings Reports

Positive Surprise Ratio

SER beat 2 of 3 last estimates.

67%

Next Report

Date of Next Report

Mar 23, 2026

Estimate for Q4 26 (Revenue/ EPS)

-$0.44

Implied change from Q3 25 (Revenue/ EPS)

-13.73%

Implied change from Q4 25 (Revenue/ EPS)

Serina Therapeutics, Inc. earnings per share and revenue

On Nov 13, 2025, SER reported earnings of -0.51 USD per share (EPS) for Q3 25, beating the estimate of -0.53 USD, resulting in a 4.73% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.49% price change (close before vs. close after earnings).

Looking ahead to Q4 26, 3 analysts forecast an EPS of -0.44 USD, with revenue projected to reach -- USD, implying an decrease of -13.73% EPS, and increase of 0.00% in Revenue from the last quarter.

FAQ

What were Serina Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Serina Therapeutics, Inc. reported EPS of -$0.51, beating estimates by 4.73%, and revenue of $0.00, 0% as expectations.

How did the market react to Serina Therapeutics, Inc.'s Q3 2025 earnings?

The stock price moved down -2.49%, changed from $4.02 before the earnings release to $3.92 the day after.

When is Serina Therapeutics, Inc. expected to report next?

The next earning report is scheduled for Mar 23, 2026.

What are the forecasts for Serina Therapeutics, Inc.'s next earnings report?

Based on 3 analysts, Serina Therapeutics, Inc. is expected to report EPS of -$0.44 and revenue of -- for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.